You are asking the right question, how much do they need?
I did some math a few weeks back (can't remember what thread it was on), but essentially it gave a range of cash that was needed. To be honest, I do not know, we can only try and work backwards from what they have reported.
I suggest we should be thinking they need to jab / test between 300 to 650 people at a cost of circa US$50k each. I would err on the high side, given I think the FDA will ask for all the same monitoring from phase 1
I will dig out those previous thoughts.
Where we at?, page-405
-
- There are more pages in this discussion • 302 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |